Sign up to save your podcasts
Or
Share Primary Care Update Episode 13
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Primary Care Update Episode 13
Today we talk about the impact of more primary care physicians in a population on health outcomes; whether or not probiotics, prebiotics, and antibiotics are helpful for irritable bowel; and the impact of SGLT-2 inhibitors like empagliflozin on cardiovascular outcomes in diabetics with heart disease or at very high risk.
View all episodes
By Mark Ebell
4.7
9292 ratings
Today we talk about the impact of more primary care physicians in a population on health outcomes; whether or not probiotics, prebiotics, and antibiotics are helpful for irritable bowel; and the impact of SGLT-2 inhibitors like empagliflozin on cardiovascular outcomes in diabetics with heart disease or at very high risk.
More shows like Primary Care Update
View all
JAMA Editors' Summary
137 Listeners
AFP: American Family Physician Podcast
700 Listeners
JAMA Clinical Reviews
497 Listeners
Mayo Clinic Talks
288 Listeners
GeriPal - A Geriatrics and Palliative Medicine Podcast
283 Listeners
Frankly Speaking About Family Medicine
262 Listeners
The Curbsiders Internal Medicine Podcast
3,342 Listeners
Core IM | Internal Medicine Podcast
1,153 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
86 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
365 Listeners
Run the List
248 Listeners
The Curious Clinicians
370 Listeners
The Cribsiders
314 Listeners